ESAL: A Tool for the Explanatory Prediction of Loss of Patency Within 1 Year After Iliac Vein Stent Placement

Abstract

Objective:

Establish a predictive tool for assessing post-iliac vein stent placement (IVSP) patency loss within 1 year.

Background:

Post-IVSP stent surveillance is vital for detecting stent malfunction and guiding interventions. Despite extensive research on vascular patency after IVSP, individual risks for patency loss remain understudied.

Materials and Methods:

We developed a predictive model for assessing patency loss risk within 1 year after IVSP using data from 162 patients. Cox regression and the Boruta method identified risk factors, leading to the construction of a random forest (RF) model. We validated the model’s performance using testing data and developed a user-friendly risk tool, the Etiology-Stenosis-Age-Length (ESAL) Classification.

Results:

The RF model demonstrated excellent performance, with high sensitivity, specificity, and negative predictive value. Risk factors identified included younger age, post-thrombotic lesions, short-segment occlusions, and preoperative target lesion occlusion. Shapley Additive exPlanations analysis and Cox regression enhanced model interpretability.

Conclusions:

We present a novel, intuitive model for assessing patency loss risk after IVSP. The ESAL classification provides clinicians with a practical tool to identify high-risk patients. Future research should focus on larger, more representative cohorts to validate and refine the model.

Clinical Impact

How will this change clinical practice?

The risk of iliac vein stent patency loss within one year post-placement can be predicted in advance.

What does it mean for the clinicians?

The newly introduced Etiology-Stenosis-Age-Length (ESAL) Classification offers clinicians a practical and user-friendly tool for identifying high-risk patients who may experience patency loss after iliac vein stent placement.

What is the innovation behind the study?

Researchers have successfully developed a predictive model for assessing the risk of iliac vein stent patency loss within one year post-placement.

Keywords

iliac vein stent placement vascular patency risk factor predictive model Etiology-Stenosis-Age-Length Classification

Get full access to this article

View all access options for this article.

References

Taha

MAH

Busuttil

Bootun

, et al A clinical guide to deep venous stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2022;10:258–266.e1.

Villalba

Bayat

Dubenec

, et al Australian and New Zealand Society for Vascular Surgery clinical practice guidelines on venous outflow obstruction of the femoral-iliocaval veins. J Vasc Surg Venous Lymphat Disord. 2023;11:832–842.

Clinical trials of the efficacy and safety of venous stenting systems in the treatment of iliac femoral vein occlusion have been prospective, multicenter, single-group targets. 2023. https://www.chictr.org.cn/hvshowprojectEN.html?id=230092&v=1.0

Razavi

Marston

Black

, et al The initial report on 1-year outcomes of the feasibility study of the Veniti Vici venous stent in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2018;6:192–200.

Razavi

Black

Gagne

, et al Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction. Circ Cardiovasc Interv. 2019;12:e008268.

Hofmann

Gagne

Brown

, et al Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study). J Vasc Surg Venous Lymphat Disord. 2023;11:532–541.e4.

Jayaraj

Fuller

Raju

, et al In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2022;10:42–51.

Neglén

Raju

Balloon dilation and stenting of chronic iliac vein obstruction: technical aspects and early clinical outcome. J Endovasc Ther. 2000;7:79–91.

Raju

Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013;57:1163–1169.

10.

Black

Gwozdz

Karunanithy

, et al Two year outcome after chronic iliac vein occlusion recanalisation using the Vici Venous Stent®. Eur J Vasc Endovasc Surg. 2018;56:710–718.

11.

Neglén

Tackett

Jr Raju

Venous stenting across the inguinal ligament. J Vasc Surg. 2008;48:1255–1261.

12.

Mahnken

Thomson

de Haan

, et al CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol. 2014;37:889–897.

13.

Robertson

Shapiro

Muck

, et al Venous stent patency is independent of total stented length in nonthrombotic iliac vein and post-thrombotic venous stenoses. J Vasc Surg Venous Lymphat Disord. 2023;11:339–345.

14.

Collins

Reitsma

Altman

, et al Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.

15.

Sheng

Shi

, et al One-year outcomes of a novel venous stent for symptomatic iliofemoral venous obstruction: prospective cohort study. BMC Med. 2024;22:324.

16.

Milinis

Thapar

Shalhoub

, et al Antithrombotic therapy following venous stenting: international Delphi consensus. Eur J Vasc Endovasc Surg. 2018;55:537–544.

17.

van Buuren

Groothuis-Oudshoorn

. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.

18.

Degenhardt

Seifert

Szymczak

Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20:492–503.

19.

Leme

DEDC

de Oliveira

Machine learning models to predict future frailty in community-dwelling middle-aged and older adults: the ELSA cohort study. J Gerontol A Biol Sci Med Sci. 2023;78:2176–2184.

20.

Yang

Zhang

, et al Prediction models of surgical site infection after gastrointestinal surgery: a nationwide prospective cohort study. Int J Surg. 2023;110:119–129.

21.

Wang

Song

, et al Risk factors prediction of 6-month mortality after noncardiac surgery of older patients in China: a multicentre retrospective cohort study. Int J Surg. 2023;110:219–228.

22.

Chawla

Bowyer

Hall

, et al SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321–357.

23.

Bernd Bischl

Kotthoff

Lang

Applied Machine Learning Using mlr3 in R. CRC Press; 2024.

24.

Lei

, et al Developing and optimizing a machine learning predictive model for post-thrombotic syndrome in a longitudinal cohort of patients with proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2023;11:555–564.e5.

25.

Couronné

Probst

Boulesteix

AL.

Random forest versus logistic regression: a large-scale benchmark experiment. BMC Bioinformatics. 2018;19:270.

26.

Lundberg

Lee

S.-I.

A unified approach to interpreting model predictions, in Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates Inc.: Long Beach, CA, 2017, pp. 4768–4777.

27.

Saleem

Barry

Thaggard

, et al Iliac vein stent failure in community practice and results of corrective reinterventions. J Vasc Surg Venous Lymphat Disord. 2023;11:525–531.e3.

28.

Xiang

Yang

Qian

, et al Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: a multicentre retrospective study. EClinicalMedicine. 2024;67:102378.

29.

Moini

Zafarghandi

Taghavi

, et al Venoplasty and stenting in post-thrombotic syndrome and non-thrombotic iliac vein lesion. Minim Invasive Ther Allied Technol. 2020;29:35–41.

30.

Lichtenberg

MKW

Stahlhoff

, et al Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions—long-term efficacy and safety results from the Arnsberg venous registry. Vasa. 2021;50:52–58.

31.

Baccellieri

Ardita

Apruzzi

, et al Endovascular treatment of iliofemoral vein obstruction below the inguinal ligament using a new-dedicated stent: early experience from a single center. Int Angiol. 2021;40:187–195.

32.

Lipton

ZC.

The Mythos of Model Interpretability: in machine learning, the concept of interpretability is both important and slippery. Queue. 2018;16:31–57.

33.

Chi

Guo

Heard

, et al Development and structure of an accurate machine learning algorithm to predict inpatient mortality and hospice outcomes in the coronavirus disease 2019 era. Med Care. 2022;60:381–386.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.21 MB

0.14 MB

0.20 MB